Chemoradiotherapy of NSCLC Stage IIIB
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Study ID
- NCT00198432
- Phase
- PHASE2
- Status
- Completed
Conditions
- Concomitant Radiochemotherapy
- NSCLC Stage IIIB
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
Study Details
To evaluate the best timing of the concomitant chemoradiotherapy among patients with NSCLC stage III not resectable treated by concomitant chemo-radiotherapy, either preceded by a induction chemotherapy, or followed by a consolidation chemotherapy.
Key Dates
- Start date
- Mar 31, 2002
- Status verified
- Mar 2016
- Completion
- Dec 31, 2006
Study Design
- Enrollment
- 130 participants
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Primary Outcome Measure
Objective response rate